http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#head http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#assertion http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#provenance http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#publicationInfo http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#assertion http://bio2rdf.org/drugbank:DB06268 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://bio2rdf.org/drugbank:DB08895 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://purl.org/dc/terms/identifier drugbank_resource:DB06268_DB08895 http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://purl.org/dc/terms/title DDI between Sitaxentan and Tofacitinib - Sitaxentan (moderate CYP3A4 inhibitors, strong CYP2C19 inhbitors), when used in combination with tofacitinib, may increase tofaciitinib serum concentration toxicity and adverse effects. It is recommended to adjust therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5 mg daily. http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB06268_DB08895 http://www.w3.org/2000/01/rdf-schema#label DDI between Sitaxentan and Tofacitinib - Sitaxentan (moderate CYP3A4 inhibitors, strong CYP2C19 inhbitors), when used in combination with tofacitinib, may increase tofaciitinib serum concentration toxicity and adverse effects. It is recommended to adjust therapy by reducing the adult dose of tofacitinib from 5mg twice a day to 5 mg daily. [drugbank_resource:DB06268_DB08895] http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#provenance http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#publicationInfo http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#signature.MCwCFB7ISMQM0aDX http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#signature.MCwCFB7ISMQM0aDX http://purl.org/nanopub/x/hasSignature MCwCFB7ISMQM0aDXWz3vHLqf0nv/JihmAhQjCBFRCiGIvW8k8nk9EhUk16clVA== http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#signature.MCwCFB7ISMQM0aDX http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://purl.org/dc/terms/created 2018-03-30T11:12:45.154+02:00 http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0#signature.MCwCFB7ISMQM0aDX http://bio2rdf.org/drugbank_resource:DB06268_DB08895_nanopub.RAU2cMzWnMyZL3OBLUP0eUM9_ocPgKs1xk0iXLW_GaJT0 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234